SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-20-281203
Filing Date
2020-10-29
Accepted
2020-10-29 17:24:53
Documents
3
Group Members
BETA ACQUISITION CORP.

Document Format Files

Seq Description Document Type Size
1 SC 13D d45739dsc13d.htm SC 13D 99511
2 EXHIBIT 3 d45739dex993.htm EX-99.3 3949
3 EXHIBIT 4 d45739dex994.htm EX-99.4 40507
  Complete submission text file 0001193125-20-281203.txt   145746
Mailing Address 2 RIGHTER PARKWAY, SUITE 200 WILMINGTON DE 19803
Business Address 35 WILBUR ST LYNBROOK NY 11563 302-842-8450
BIOSPECIFICS TECHNOLOGIES CORP (Subject) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-79091 | Film No.: 201273753
SIC: 2834 Pharmaceutical Preparations

Mailing Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000
Business Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000 353-1-268-2000
Endo International plc (Filed by) CIK: 0001593034 (see all company filings)

IRS No.: 680683755 | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations